MYELODYSPLASTIC SYNDROME (MDS)/AML
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS)/AML explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS)/AML trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS)/AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR t therapy takes on tough leukemia
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD64 CAR T cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack leukemia cells. The m…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)/AML
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Precision radiation may boost transplant success in tough leukemia cases
Disease control Recruiting nowThis study tests a precise type of radiation called proton total marrow irradiation (TMI) given before a stem cell transplant for people with high-risk acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The goal is to see if adding TMI to standard chemotherapy is saf…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)/AML
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC